Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.27 USD | -1.69% | -6.80% | -17.44% |
22/04 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
28/03 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.44% | 3.18B | |
+3.31% | 32.09B | |
+15.09% | 7.56B | |
+21.60% | 3.85B | |
-27.80% | 1.23B | |
-31.01% | 1.17B | |
-34.81% | 911M | |
+3.51% | 906M | |
-25.45% | 860M | |
-13.92% | 730M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health Reports Higher Q4 Earnings, Revenue; 2022 Revenue Guidance Issued